Notice of Results
Novacyt S.A. announced that it will release its unaudited interim results for the six months ending 30 June 2026 on Wednesday, 30 September 2026. The company will host an investor webinar at 9:00 AM BST on the same day, featuring presentations from CEO Lyn Rees and CFO Steve Gibson, followed by a Q&A session. Investors can submit questions in advance or during the live presentation via the Investor Meet Company platform.
Select text to share a quote on X · sign in to keep highlights & notes in your NCYT notes
Paris, France, and Manchester, UK – 23 September 2026 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), the international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces that it will report its unaudited interim results for the six months ended 30 June 2026 on Wednesday 30 September 2026.
Investor webinar
An investor presentation by Lyn Rees, Chief Executive Officer, and Steve Gibson, Chief Financial Officer will take place at 9.00am BST on Wednesday 30 September 2026.
The webinar is open to all existing and potential investors, and will consist of a presentation followed by a Q&A session, held on the Investor Meet Company platform. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00am the day before the meeting or at any time during the live presentation.
Investors can sign up for the webinar via:
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.